Corrigendum to "Recombinant fowlpox virus vector-based vaccine completely protects chickens from H5N1 avian influenza virus" [Antiviral Res. 81 (3) (2009) 234-238] (DOI:10.1016/j.antiviral.2008.12.002);Recombinant fowlpox virus vector-based vaccine completely protects chickens from H5N1 avian influenza virus

Antiviral Research

Volumn 81, Issue 3, 2009, Pages 234-238

  Qiao, Chuanling ^a   Jiang, Yongping ^a   Tian, Guobin ^a   Wang, Xiurong ^a   Li, Chengjun ^a   Xin, Xiaoguang ^a   Chen, Hualan ^a   Yu, Kangzhen ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Avian influenza virus; H5N1; Recombinant fowlpox virus; Vaccine

Indexed keywords

RECOMBINANT FOWLPOX VIRUS HEMAGGLUTININ NEURAMINIDASE VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVIAN INFLUENZA; CHICKEN; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FOWLPOX VIRUS; INFECTION CONTROL; INFLUENZA VIRUS A H5N1; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; VACCINATION;

AVES; AVIAN INFLUENZA VIRUS; FOWLPOX VIRUS; GALLUS GALLUS; ORTHOMYXOVIRIDAE;

EID: 60549091351     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.07.019     Document Type: Erratum

References (32)

1. Alexander D.J. An overview of the epidemiology of avian influenza. Vaccine 26 (2007) 5637-5644
2. Amonsin A., Payungporn S., Theamboonlers A., Thanawongnuwech R., Suradhat S., Pariyothorn N., Tantilertcharoen R., Damrongwantanapokin S., Buranathai C., Chaisingh A., Songserm T., and Poovorawan Y. Genetic characterization of H5N1 influenza A viruses isolated from zoo tigers in Thailand. Virology 344 (2006) 480-491
3. Beard C.W., Schnitzlein W.M., and Tripathy D.N. Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses. Avian Dis. 35 (1991) 356-359
4. Beard C.W., Schnitzlein W.M., and Tripathy D.N. Effect of route of administration on the efficacy of a recombinant fowlpox virus against H5N2 avian influenza. Avian Dis. 36 (1992) 1052-1055
5. Boyle D.B. Quantitative assessment of poxvirus promoters in fowlpox and vaccinia virus recombinants. Virus Genes 6 (1992) 281-290
6. Boyle D.B., and Coupar B.E. Construction of recombinant fowlpox viruses as vectors for poultry vaccines. Virus Res. 10 (1988) 343-356
7. Boyle D.B., and Heine H.G. Recombinant fowlpox virus vaccines for poultry. Immunol. Cell Biol. 71 (1993) 391-397
8. Boyle D.B., and Heine H.G. Influence of dose and route of inoculation on responses of chickens to recombinant fowlpox virus vaccines. Vet. Microbiol. 41 (1994) 173-181
9. Brown D.W., Kawaoka Y., Webster R.G., and Robinson H.L. Assessment of retrovirus-expressed nucleoprotein as a vaccine against lethal influenza virus infections of chickens. Avian Dis. 36 (1992) 515-520
10. Bublot M., Pritchard N., Cruz J.S., Mickle T.R., Selleck P., and Swayne D.E. Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge. Avian Dis. 51 Suppl. 1 (2007) 498-500
11. Bublot M., Pritchard N., Swayne D.E., Selleck P., Karaca K., Suarez D.L., Audonnet J.C., and Mickle T.R. Development and use of fowlpox vectored vaccines for avian influenza. Ann. N.Y. Acad. Sci. 1081 (2006) 193-201
12. Chamber T., Kawaoka Y., and Webster R.G. Protection of chickens from lethal influenza infection by vaccinia expressed hemagglutinin. Virology 167 (1988) 414-421
13. Chen H., Deng G., Li Z., Tian G., Li Y., Jiao P., Zhang L., Liu Z., Webster R.G., and Yu K. The evolution of H5N1 influenza viruses in ducks in southern China. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 10452-10457
14. Chen Z., Kadowaki S., Hagiwara Y., Yoshikawa T., Matsuo K., Kurata T., and Tamura S. Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. Vaccine 18 (2000) 3214-3222
15. Ellis T.M., Leung C.Y., Chow M.K., Bissett L.A., Wong W., Guan Y., and Peiris M. Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission. Avian Pathol. 33 (2004) 405-412
16. Ge J., Deng G., Wen Z., Tian G., Wang Y., Shi J., Wang X., Li Y., Hu S., Jiang Y., Yang C., Yu K., Bu Z., and Chen H. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J. Virol. 81 (2007) 150-158
17. Jiang Y., Yu K., Zhang H., Zhang P., Li C., Tian G., Li Y., Wang X., Ge J., Bu Z., and Chen H. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector. Antiviral Res. 75 (2007) 234-241
18. Johansson B.E., Ducher D.J., and Kilbourne E.D. Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J. Virol. 63 (1989) 1239-1246
19. Karaca K., Swayne D.E., Grosenbaugh D., Bublot M., Robles A., Spackman E., and Nordgren R. Immunogenicity of fowlpox virus expressing the avian influenza virus H5 gene (TROVAC AIV-H5) in cats. Clin. Diagn. Lab. Immunol. 12 (2005) 1340-1342
20. Kodihalli S., Goto H., and Kobasa D.L. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J. Virol. 73 (1999) 2094-2098
21. Kodihalli S., Sivanandan V., Nagaraja K.V., Shaw D., and Halvorson D.A. A type-specific avian influenza virus subunit vaccine for turkeys: induction of protective immunity to challenge infection. Vaccine 12 (1994) 1467-1472
22. Paoletti E. Application of poxvirus vectors to vaccination: an update. Proc. Acad. Sci. U.S.A. 93 (1996) 11349-11353
23. Qiao C.L., Chang H.T., Yu K.Z., and Chen H.L. Genetic stability of a recombinant fowlpox virus co-expressing H5 HA and N1 NA gene of avian influenza virus. Wei Sheng Wu Xue Bao 44 (2004) 686-688 (in Chinese)
24. Qiao C.L., Yu K.Z., Jiang Y.P., Jia Y.Q., Tian G.B., Liu M., Deng G.H., Wang X.R., Meng Q.W., and Tang X.Y. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathol. 32 (2003) 25-31
25. Qiao C., Yu K., Jiang Y., Li C., Tian G., Wang X., and Chen H. Development of a recombinant fowlpox virus vector-based vaccine of H5N1 subtype avian influenza. Dev. Biol. (Basel) 124 (2006) 127-132
26. Swayne D.E., Avellaneda G., Mickle T.R., Pritchard N., Cruz J., and Bublot M. Improvements to the hemagglutination inhibition test for serological assessment of recombinant fowlpox-H5-avian-influenza vaccination in chickens and its use along with an agar gel immunodiffusion test for differentiating infected from noninfected vaccinated animals. Avian Dis. 51 (2007) 697-704
27. Swayne D.E., Beck J.R., and Kinney N. Failure of a recombinant fowlpox virus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. Avian Dis. 44 (2000) 132-137
28. Swayne D.E., Beck J.R., and Mickle T.R. Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus. Avian Dis. 41 (1997) 910-922
29. Thiry E., Zicola A., Addie D., Egberink H., Hartmann K., Lutz H., Poulet H., and Horzinek M.C. Highly pathogenic avian influenza H5N1 virus in cats and other carnivores. Vet. Microbiol. 122 (2007) 25-31
30. Tian G., Zhang, Li Y., Bu Z., Liu P., Zhou J., Li C., Shi J., Yu K., and Chen H. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology 341 (2005) 153-162
31. Van Der Goot J.A., Koch G., De Jong M.C., and Van Boven M. Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 18141-18146
32. Xu X., Subbarao K., Cox N.J., and Guo Y. Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96(H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 261 (1999) 15-19